Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$436M |
| 2 |
United Therapeutics
UTHR
|
+$393M |
| 3 |
Amazon
AMZN
|
+$376M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$372M |
| 5 |
Visa
V
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$313M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$272M |
| 3 |
Stellantis
STLA
|
+$222M |
| 4 |
TSMC
TSM
|
+$215M |
| 5 |
Bank of America
BAC
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.76% |
| 2 | Consumer Discretionary | 6.77% |
| 3 | Healthcare | 6.2% |
| 4 | Financials | 5.48% |
| 5 | Communication Services | 4.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3776
American Express Global Business Travel
GBTG
$4.92B
| $181K | ﹤0.01% |
27,429
+9,942
| +57% | +$61K |
|
3777
KraneShares Global Carbon Strategy ETF
KRBN
$139M
| $180K | ﹤0.01% |
5,543
-1,103
| -17% | -$36.4K |
|
3778
ProKidney
PROK
$316M
| $180K | ﹤0.01% |
73,149
+64,499
| +746% | +$173K |
|
|
ETWO
3779
DELISTED
E2open Parent Holdings
ETWO
| $180K | ﹤0.01% |
40,030
+6,105
| +18% | +$27.5K |
|
3780
Zentalis Pharmaceuticals
ZNTL
$332M
| $180K | ﹤0.01% |
43,926
-213,161
| -83% | -$2.38M |
|
3781
EyePoint Inc
EYPT
$999M
| $180K | ﹤0.01% |
20,646
-69,316
| -77% | -$968K |
|
|
UDMY
3782
DELISTED
Udemy
UDMY
| $180K | ﹤0.01% |
20,809
+6,012
| +41% | +$57K |
|
3783
Ares Capital
ARCC
$13.4B
| $179K | ﹤0.01% |
8,602
+3,212
| +60% | +$67.1K |
|
3784
NYLI FTSE International Equity Currency Neutral ETF
HFXI
$1.96B
| $179K | ﹤0.01% |
6,703
-3,502
| -34% | -$93.8K |
|
|
VMEO
3785
DELISTED
Vimeo
VMEO
| $179K | ﹤0.01% |
47,980
-9,820
| -17% | -$37.2K |
|
|
PLGO
3786
Pelagos Insurance Capital
PLGO
$2.18B
| $179K | ﹤0.01% |
10,969
-4,109
| -27% | -$72.8K |
|
3787
Replimune Group
REPL
$454M
| $179K | ﹤0.01% |
19,863
-522,626
| -96% | -$3.64M |
|
3788
Heron Therapeutics
HRTX
$93.4M
| $177K | ﹤0.01% |
50,480
+33,017
| +189% | +$101K |
|
3789
Vanguard Mega Cap Value ETF
MGV
$13.1B
| $177K | ﹤0.01% |
1,490
-35
| -2% | -$4.12K |
|
3790
Companhia Siderúrgica Nacional
SID
$1.37B
| $175K | ﹤0.01% |
76,272
+2,806
| +4% | +$7.39K |
|
|
CGAU
3791
Centerra Gold
CGAU
$3.38B
| $175K | ﹤0.01% |
26,070
-1,758,662
| -99% | -$11.5M |
|
3792
Allogene Therapeutics
ALLO
$625M
| $175K | ﹤0.01% |
75,172
-603,057
| -89% | -$1.78M |
|
3793
Resources Connection
RGP
$140M
| $175K | ﹤0.01% |
15,860
-35,179
| -69% | -$396K |
|
|
TDAY
3794
USA Today Co
TDAY
$1.29B
| $175K | ﹤0.01% |
37,858
+9,997
| +36% | +$33.4K |
|
3795
Stoneridge
SRI
$200M
| $174K | ﹤0.01% |
10,894
+1,819
| +20% | +$29.1K |
|
3796
American Superconductor
AMSC
$1.29B
| $174K | ﹤0.01% |
7,427
-32,978
| -82% | -$545K |
|
3797
Alignment Healthcare
ALHC
$3.78B
| $174K | ﹤0.01% |
22,198
+7,179
| +48% | +$46.9K |
|
|
AMPS
3798
DELISTED
Altus Power
AMPS
| $174K | ﹤0.01% |
44,278
+2,586
| +6% | +$10.7K |
|
|
ITOS
3799
DELISTED
iTeos Therapeutics
ITOS
| $174K | ﹤0.01% |
11,695
-284,289
| -96% | -$4.07M |
|
3800
Mizuho Financial
MFG
$120B
| $173K | ﹤0.01% |
40,957
+5,871
| +17% | +$23.3K |
|
Similar funds
Citigroup's Q2 2024 Portfolio in Review
As of Q2 2024, Citigroup held 5,888 positions worth $156B, up 2.5% from $152B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citigroup's Q2 2024 filing shows 274 new, 2,819 increased, 1,798 reduced and 330 closed positions. Its largest new stake was Ferrovial N.V. Ordinary Shares: 8,935,948 shares worth $344M. The largest sale was iShares MSCI EAFE ETF, an estimated $313M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Citigroup's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 8,935,948 shares worth $344M.
- Citigroup added most to Intel in Q2 2024, an estimated $436M increase.
- Citigroup's biggest Q2 2024 reduction was iShares MSCI EAFE ETF, cutting an estimated $313M.
- Citigroup fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $79.7M.
- Citigroup's ten largest holdings make up 22% of its $156B portfolio in Q2 2024.
- Citigroup opened 274 new positions and closed 330 in Q2 2024.
- Citigroup's portfolio value rose 2.5% quarter-over-quarter to $156B.
Based on Citigroup's 13F filing for Q2 2024, filed 12 Aug 2024.